Errors during transcription may play an important role in determining 11 cellular phenotypes: the RNA polymerase error rate is >4 orders of magnitude 12 higher than that of DNA polymerase and errors are amplified >1000-fold due to 13 translation. However, current methods to measure RNA polymerase fidelity are low-14 throughout, technically challenging, and organism specific. Here I show that changes 15 in RNA polymerase fidelity can be measured using standard RNA sequencing 16 protocols. I find that RNA polymerase is error-prone, and these errors can result in 17 splicing defects. Furthermore, I find that differential expression of RNA polymerase 18 subunits causes changes in RNA polymerase fidelity, and that coding sequences may 19 have evolved to minimize the effect of these errors. These results suggest that errors 20 caused by RNA polymerase may be a major source of stochastic variability at the 21 level of single cells. 22
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The information that determines protein sequence is stored in the genome 24 but that information must be transcribed by RNA polymerase and translated by the 25 ribosome before reaching its final form. DNA polymerase error rates have been well 26 characterized in a variety of species and environmental conditions, and are low, on 27 the order of one mutation per 10 8 -10 10 bases per generation 1-3 . In contrast, RNA 28 polymerase errors are uniquely positioned to generate phenotypic diversity. Error 29 rates are high (10 -6 -10 -5 ) 4-7 , and each mRNA molecule is translated into 2,000 -30 4,000 molecules of protein 8, 9 , resulting in amplification of any errors. Likewise, 31 because many RNAs are present in less than one molecule per cell in microbes 10,11 32 and embryonic stem cells 12 , an RNA with an error may be the only RNA for that 33 gene; all newly translated protein will contain this error. Despite the fact that 34 transient errors can result in altered phenotypes 13, 14 , the genetics and 35 environmental factors that affect RNA polymerase fidelity are poorly understood. 36 This is because current methods for measuring polymerase fidelity are technically 37 challenging 4 , require specialized organism-specific genetic constructs 15 , and can 38 only measure error rates at specific loci 16 . 39 40 To overcome these obstacles I developed MORPhEUS (Measurement Of RNA 41
Polymerase Errors Using Sequencing), which enables measurement of differential 42 RNA polymerase fidelity using existing RNA-seq data (Figure 1) . The input is a set 43 of RNA-seq fastq files and a reference genome, and the output is the error rate at 44 each position in the genome. I find that RNA polymerase errors result in intron 45 retention and that cellular mRNA quality control may reduce the effective RNA 46 Page 3 of 18 polymerase error rate. Moreover, our analyses suggest that the expression level of 47 the RPB9 Pol II subunit determines RNA polymerase fidelity in-vivo. Because it can 48 be run on any existing RNA-seq data, MORPhEUS enables the exploration of a 49 previously unexplored source of biological diversity in microbes and mammals. 50 51 Technical errors from reverse transcription and sequencing, and biological 52 errors from RNA polymerase look identical (single-nucleotide differences from the 53 reference genome). Therefore, a major challenge in identifying SNPs and in 54 measuring changes in polymerase fidelity is the reduction of technical errors 17-55 19 (Figure 1) . First, I map full length (untrimmed) reads to the genome, and discard 56 reads with indels, more than two mismatches, reads that map to multiple locations 57 in the genome, and reads that do not map end-to-end along the full length of the 58 read. I next trim the ends of the mapped reads, as alignments are of lower quality 59 along the ends, and the mismatch rate is higher, especially at splice junctions. I also 60 discard any cycles within the run with abnormally high error rates, and bases with 61 low Illumina quality scores (Figure 1 -figure supplement 1) . Finally, using the 62 remaining bases, I count the number of matches and mismatches to the reference 63 genome at each position in the genome. I discard positions with identical 64 mismatches that are present more than once, as these are likely due to subclonal 65 DNA polymorphisms or sequences that Illumina miscalls in a systematic manner 20 66 ( Figure 1 -figure supplement 2) . The result is a set of mismatches, many of which 67 are technical errors, some of which are RNA polymerase errors. In order to 68 determine if RNA-seq mismatches are due to RNA polymerase errors it is necessary a measurable effect, or situations in which RNA polymerase fidelity is expected to 71 vary. 72 73 I reasoned that RNA polymerase errors that alter positions necessary for 74 splicing should result in intron retention, while sequencing errors should not affect 75 the final structure of the mRNA (Figure 2a ). However, mutations in the donor and 76 acceptor splice sites also result in decreased expression 36 , and therefore are difficult 77 to measure using RNA-seq. I therefore used chromatin-associated and nuclear RNA 78 from Hela and Huh7 cells 37 , and extracted all reads that span an exon-intron 79 junction for introns with canonical GT and AG splice sites, and measured the RNA-80 seq mismatch rate at each position. I find that errors at the G and U in the 5' donor RNA polymerase mismatches can result in changes in transcript isoforms. The 85 ability of RNA polymerase errors to significantly affect splicing has been proposed 22 86 but never previously measured. 87 88 RPB9 is known to be involved in RNA polymerase fidelity in vitro and in 89 vivo 15,23 . I therefore reasoned that cell lines expressing low levels of RPB9 would 90 have higher RNA polymerase error rates. Consistent with this, I find that RPB9 91 expression varies 8-fold across the ENCODE cell lines, and this expression variation 2). This suggests that low RPB9 expression may cause decreased polymerase 94 fidelity in-vivo. 95
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In addition, export of mRNAs from the nucleus involves a quality-control 97 mechanism that checks if mRNAs are fully spliced and have properly formed 5' and 98 3' ends 24 . I hypothesized that mRNA export may involve a quality control that 99 removes mRNAs with errors. I used the ENCODE dataset in which nuclear and 100 cytoplasmic poly-A+ mRNAs I re sequenced, thus I can compare nuclear and 101 cytoplasmic fractions from the same cell line grown in the same conditions and 102 processed in the same manner. I find that the nuclear fraction has a higher RNA 103 polymerase error rate than does the cytoplasmic fraction (Figure 2c,d ), suggesting 104 that either that nuclear RNA-seq has a higher technical error rate or that the cell has 105 mechanisms for reducing the effective polymerase error rate by preventing the 106 export of mRNAs that contain errors. 107 108 Rpb9 and Dst1 are known to be involved in RNA polymerase fidelity in-vitro, 109 yet there is conflicting evidence as to the role of Dst1 in-vivo 6,15,23,25-27 . Part of these 110 conflicts may result from the fact that the only available assays for RNA polymerase 111 fidelity are special reporter strains that rely on DNA sequences known to increase 112 the frequency of RNA polymerase errors. While I found that RPB9 expression 113 correlates with RNA-seq error rates in mammalian cells, correlation is not 114 causation. Furthermore, differences in RNA levels do not necessitate differences in 115 Page 6 of 18 stoichiometry among the subunits in active Pol II complexes. In order to determine 116 if differential expression of RPB9 or DST1 are causative for differences in RNA 117 polymerase fidelity in-vivo, I constructed two yeast strains in which I can alter the 118 expression of either RPB9 or DST1 using B-estradiol and a synthetic transcription 119 factor that has no effect on growth rate or the expression of any other genes 28,29 . I 120 grew these two strains ( Z 3 EV pr -RPB9 and Z 3 EV pr -DST1 ) in different concentrations 121 The increase in error rates due to mutations in Rpb9 and Dst1 have not been 126 robustly measured, however, there are some rough numbers. Here, the measured 127 increase in error rate is 13%, while the measured effect of Rpb9 deletion in-vitro is 128 5-fold 38 and in-vivo following reverse transcription is 30% 25 . If 2% of the observed 129 mismatches are due to RNA polymerase errors, a 5-fold increase in polymerase 130 error rate results in a 10% increase in measured mismatch frequency; this is 131 consistent with RNA polymerase fidelity of 10 -6 -10 -5 and overall RNA-seq error rates 132 of 10 -4 . Note that in our assay cells still express low levels or RPB9, and we therefore 133 expect the increase in error rate to be lower, suggesting that RNA polymerase errors 134 constitute 5-10% of the measured mismatches. Our ability to genetically control the 135 expression of DST1 and RPB9, and measure changes in RNA-seq error rates is 136 consistent with MORPhEUS measuring RNA polymerase fidelity. In addition, we 137 observe more single nucleotide insertions in the RNA-seq data from the high error splicing efficiency (Figure 3b) . shown that DNA and RNA polymerase have broadly similar error profiles 2 ; it will be 152 interesting to see if all polymerases share the same mutation spectra, and if this is 153 due to deamination of the template base, or is a structural property of the 154 polymerase itself. Interestingly, I find that coding sequences have evolved so that 155 errors are less likely to produce in-frame stop codons than out-of-frame stop 156 codons, suggesting that natural selection may act to minimize the effect of 157 polymerase errors (Figure 4) . The diagonal lines show mismatch frequencies of 100%, 10%, 1% and 0.1% -any point falling on these lines has the given mismatch frequency. With large grey circles are shown simulated data in which the same coverage as the yeast RNA-seq data are used, but with a mismatch frequency identical to the measured overall mismatch frequency of the yeast data. Locations in the graph in which a black point occurs but there is no grey point are locations in which there are more mismatches than expected by change. Note that at a coverage of less than 100, we expect to see no mismatches more than twice, and 0.5% of positions with 2 observances of identical mismatches. (b) Identical to (a) but with the simulated mismatch frequency 5x the observed.
(c) Shown are measured mismatch frequencies for the yeast RPB9 and DST1 induction data at different B-estradiol concentrations, at different filters for the maximal allowed number of observed identical mismatches. The dashed lines show the average mismatch frequency for the 0nM condition. For all filters, low B-estradiol conditions have higher RNA-seq mismatch frequencies.
(d) The coverage of the yeast RNA-seq data; ~95% of the genome is covered by less than 100 reads. (e) Shown are the fraction of positions in the genome (y-axis) with X errors (x-axis) for the yeast RNAseq data (cyan) and simulated data (blue). Also shown are the same data for positions of the genome with different coverage. For positions covered by less than 1000 reads (95% of the genome) the expectation is 0 or 1 sequence mismatch (blue and orange lines). Positions with far greater numbers of mismatches are likely due to subclonal mutations and technical bias. 
